Oncology Partnership Buy-In: What It Costs and How to Pay
An oncology partnership buy-in is often the moment a young oncologist moves from employee to owner. After a period of employment with an independent group, an associate may be invited to purchase an ownership interest, sharing in the practice’s profits, decisions and long-term value.
Oncology buy-ins can be more complex than those in many other specialties because the practice may hold significant drug inventory, expensive equipment, ancillary services and sometimes real estate. This guide explains what a buy-in may include, how it is often priced and how physicians finance it. Partnership terms vary widely, and nothing here is legal, tax, billing or compliance advice. Healthcare counsel and accountants should review any buy-in agreement.
What You Are Actually Buying
A buy-in typically gives the new partner a share of some or all of the following:
- Goodwill: the value of the practice’s reputation, patient base and referral relationships
- Hard assets: infusion chairs, pumps, furniture, imaging and other equipment
- Drug inventory: the stock of infused and injected therapies on hand
- Accounts receivable: money owed to the practice for services already provided
- Ancillary interests: dispensing, laboratory, imaging or radiation services where present
- Real estate: sometimes held in a separate entity with its own buy-in
Each component may be priced and paid for differently. Understanding the breakdown helps a physician evaluate whether the overall price is reasonable.
How an Oncology Partnership Buy-In Is Priced
Practices use different approaches. Some base the price on an independent valuation, while others use a formula written into the partnership agreement. Factors that may affect price include the practice’s normalized earnings, drug margin, payer mix, physician ages and retirement plans, and the condition of its equipment.
Our article on oncology practice valuation explains how drug revenue and earnings affect value. A new partner should ask how the price was determined and request the supporting financial information.
Drug Inventory and Receivables
Inventory and receivables can add meaningfully to a buy-in. Some practices include them in the purchase price, while others handle them through capital contributions or adjustments to compensation over time.
Because buy-and-bill purchasing ties up cash, partners may also be asked to support the practice’s working capital. Our guide to oncology buy-and-bill cash flow explains how practices finance drug purchases.
Questions to Ask Before You Sign
Before committing, an associate should understand:
- What share of ownership the buy-in provides and whether it vests over time
- How profits, ancillary income and expenses are divided among partners
- Voting rights and how major decisions, including a sale, are made
- What happens if a partner becomes disabled, leaves or retires
- Whether the practice has received offers from hospitals, networks or private equity groups
- Existing practice debt and whether new partners take on personal liability for it
- Restrictive covenants, which should be reviewed by counsel because enforceability varies by state
Knowing how a future sale would be handled is especially important in oncology, where outside interest from larger organizations is significant.
Ways to Pay for a Buy-In
Physicians generally have several options, which may be combined:
- Practice loan: a loan to the physician to purchase the ownership interest
- Compensation adjustments: paying part of the price through reduced distributions over time
- Installment payments to the practice or partners: structured under the partnership agreement
- Personal savings: often combined with financing
SBA 7(a) loans may be used for partner buy-ins in some cases. Eligibility and terms depend on the business, the buyer, use of proceeds, program rules and lender review. Conventional practice loans follow each lender’s own underwriting and may suit physicians buying into established, profitable groups.
You can estimate potential payments with our SBA loan calculator. Estimates are for planning only and do not represent an offer or approval.
What Lenders Review for a Buy-In
Lenders financing an oncology partnership buy-in generally look at the practice’s historical cash flow, the physician’s expected compensation as a partner, personal credit, existing student debt and other obligations, and the terms of the partnership agreement. They may also review how drug costs are recorded and whether the practice has significant existing debt. Every loan is subject to approval, and nothing here is a commitment to lend.
Buying Into the Real Estate
In many groups, the building is owned by a separate entity controlled by some or all partners. Buying into that entity is often a separate decision with its own financing. Our article on cancer center real estate financing covers how practices finance owned facilities.
Timing the Buy-In
Timing can matter as much as price. Some groups offer a buy-in after a set period of employment, while others tie it to a retiring partner’s exit. An associate may want to align the buy-in with personal plans, such as a home purchase, so that obligations do not overlap more than necessary. Discussing timing early with the existing partners, and with a lender, can make the transition smoother for everyone.
Tax and Structure Considerations
How a buy-in is structured can affect taxes for both the new partner and the existing owners. Whether payments are treated as purchase of assets, purchase of equity or compensation adjustments matters, and the answer depends on the practice’s entity type and agreements. Accountants and tax advisors should review the structure before closing.
Final Thoughts
An oncology partnership buy-in can be a strong long-term investment for a physician who plans to build a career with an independent group. Understanding what the price includes, how drug inventory and ancillaries are treated, what rights come with ownership and how the purchase will be financed can help a new partner make a confident decision.
US Medical Funding helps oncologists finance partnership buy-ins and ownership transitions. Learn more about our oncology practice acquisition and buy-in financing.
